» Articles » PMID: 26292362

ΔNp63α Promotes Breast Cancer Cell Motility Through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program

Overview
Journal Cancer Res
Specialty Oncology
Date 2015 Aug 21
PMID 26292362
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Cell identity signals influence the invasive capability of tumor cells, as demonstrated by the selection for programs of epithelial-to-mesenchymal transition (EMT) during malignant progression. Breast cancer cells retain canonical epithelial traits and invade collectively as cohesive groups of cells, but the signaling pathways critical to their invasive capabilities are still incompletely understood. Here we report that the transcription factor ΔNp63α drives the migration of basal-like breast cancer (BLBC) cells by inducing a hybrid mesenchymal/epithelial state. Through a combination of expression analysis and functional testing across multiple BLBC cell populations, we determined that ΔNp63α induces migration by elevating the expression of the EMT program components Slug and Axl. Interestingly, ΔNp63α also increased the expression of miR-205, which can silence ZEB1/2 to prevent the loss of epithelial character caused by EMT induction. In clinical specimens, co-expression of various elements of the ΔNp63α pathway confirmed its implication in motility signaling in BLBC. We observed that activation of the ΔNp63α pathway occurred during the transition from noninvasive ductal carcinoma in situ to invasive breast cancer. Notably, in an orthotopic tumor model, Slug expression was sufficient to induce collective invasion of E-cadherin-expressing BLBC cells. Together, our results illustrate how ΔNp63α can drive breast cancer cell invasion by selectively engaging promigratory components of the EMT program while, in parallel, still promoting the retention of epithelial character.

Citing Articles

Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer.

Sahoo S, Ramu S, Nair M, Pillai M, San Juan B, Milioli H iScience. 2024; 27(7):110116.

PMID: 38974967 PMC: 11225361. DOI: 10.1016/j.isci.2024.110116.


Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer.

Sahoo S, Ramu S, Nair M, Pillai M, San Juan B, Milioli H bioRxiv. 2023; .

PMID: 37873432 PMC: 10592858. DOI: 10.1101/2023.09.30.558960.


Update on Epithelial-Mesenchymal Plasticity in Cancer Progression.

Fontana R, Mestre-Farrera A, Yang J Annu Rev Pathol. 2023; 19():133-156.

PMID: 37758242 PMC: 10872224. DOI: 10.1146/annurev-pathmechdis-051222-122423.


ZHX2 deficiency enriches hybrid MET cells through regulating E-cadherin expression.

He Y, Zhang Q, Chen Y, Wu Y, Quan Y, Chen W Cell Death Dis. 2023; 14(7):444.

PMID: 37460540 PMC: 10352340. DOI: 10.1038/s41419-023-05974-y.


The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation.

Haerinck J, Goossens S, Berx G Nat Rev Genet. 2023; 24(9):590-609.

PMID: 37169858 DOI: 10.1038/s41576-023-00601-0.


References
1.
Yu M, Bardia A, Wittner B, Stott S, Smas M, Ting D . Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013; 339(6119):580-4. PMC: 3760262. DOI: 10.1126/science.1228522. View

2.
Taube J, Herschkowitz J, Komurov K, Zhou A, Gupta S, Yang J . Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A. 2010; 107(35):15449-54. PMC: 2932589. DOI: 10.1073/pnas.1004900107. View

3.
DeCastro A, Dunphy K, Hutchinson J, Balboni A, Cherukuri P, Jerry D . MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition. Cell Death Dis. 2013; 4:e514. PMC: 3734833. DOI: 10.1038/cddis.2013.37. View

4.
Ding X, Park S, McCauley L, Wang C . Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem. 2013; 288(15):10241-53. PMC: 3624408. DOI: 10.1074/jbc.M112.443655. View

5.
Soysal S, Muenst S, Barbie T, Fleming T, Gao F, Spizzo G . EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer. Br J Cancer. 2013; 108(7):1480-7. PMC: 3629430. DOI: 10.1038/bjc.2013.80. View